Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

NCT ID: NCT04855825

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-05

Study Completion Date

2027-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Gait Disorders, Neurologic Motility Disorder Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic Exoskeleton Therapy

Gait rehabilitation provided using a wearable robotic exoskeleton

Group Type EXPERIMENTAL

Robotic Exoskeleton Rehabilitation

Intervention Type DEVICE

Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Conventional Gait Therapy

Gait rehabilitation provided using traditional gait therapy under the supervision of a licensed PT

Group Type ACTIVE_COMPARATOR

Conventional Gait Therapy

Intervention Type OTHER

Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Robotic Exoskeleton Rehabilitation

Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Intervention Type DEVICE

Conventional Gait Therapy

Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be diagnosed with multiple sclerosis.
* Be determined by the study staff to have moderate to severe difficulty walking but still be able to walk while using the robotic exoskeleton.
* Have some difficulty thinking and problem solving as determined by my performance on a special test that I will take during the screening visit.
* Be between the ages of 18 and 75.
* Be free from flair ups of my MS Symptoms for at least one month prior to testing.
* Discuss with study staff how to maintain a constant level of my spasticity medication (for example baclofen) throughout the study.
* Be able to walk (with the use of one or more assistive device if needed).
* Have English as my primary language.
* Be able to physically fit into the exoskeleton device: height between 60 and 76", weight under 220 lbs.
* Be able to tolerate upright standing for 30 minutes with assistance if needed.
* Have normal joint range of motion for walking as determined by study staff.
* Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE.
* Have stable blood pressure.
* Be willing and able to give informed consent.
* Be able and willing to comply with study procedures and follow directions and commands, verbal instructions, and follow-up requirements.

Exclusion Criteria

* Have a history of head injury, stroke, seizures, or any other significant neurological history other than MS.
* Have a high degree of difficulty in thinking and problem solving that prevents me from participating in the study as determined by my performance on a special test taken during the screening visit.
* Be currently taking steroids, benzodiazepines, antipsychotics, and/or neuroleptics as determined by study staff review of my medications.
* Be pregnant.
* Be completely reliant on a wheelchair.
* Have joint contracture or spasticity of any limb that limits normal range of motion during walking with assistive devices as determined by study staff.
* Have skin issues that would prevent wearing the RE.
* Have pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance.
* Have orthopedic issues or history that will interfere with walking or limit the range of motion of the lower limbs (e.g., knee replacement, inflammation)
* Have been hospitalized for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.
* Have any other medical conditions that my doctor or physical therapist feels would affect my ability to use the robotic device.
* Have a pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids \[cochlear implants\]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments.
* Have dental implants- I should discuss any dental implants with the investigators.
* Have been told by my doctor that it is unsafe for me to have a regular MRI as part of my medical care.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kessler Institute for Rehabilitation

INDUSTRY

Sponsor Role collaborator

Kessler Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ghaith J. Androwis, Ph.D.

Assistant Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kessler Foundation

West Orange, New Jersey, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ghaith J Androwis, Ph.D.

Role: primary

973-324-3565

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D-983-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ExoAtlet II For SCI Patients
NCT04215081 COMPLETED NA